NL
DERM icon

NWAM LLC’s Journey Medical DERM Stock Holding History

NWAM LLC’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,620
Closed -$41.5K – 526
2024
Q4 		$41.5K Buy
10,620
+190
+2% +$1.04K ﹤0.01% 590
2024
Q3 		$58.9K Buy
+10,430
New +$53.7K ﹤0.01% 613
2024
Q2 		– Sell
-11,820
Closed -$40.7K – 232
2024
Q1 		$40.7K Buy
+11,820
New +$51.4K ﹤0.01% 550

Other funds holding DERM

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

NWAM LLC's DERM Position: Q1 2025 in Review

NWAM LLC sold out of Journey Medical (DERM) in Q1 2025, closing a stake of 10,620 shares — an estimated $41.5K sold.

NWAM LLC first reported a position in DERM in Q1 2024 and held it in 3 quarters. The position peaked at $58.9K in Q3 2024. 38 funds tracked by Wall St. Rank hold DERM as of Q1 2025.

  • NWAM LLC reported no remaining Journey Medical position as of Q1 2025 after selling out during the quarter.
  • NWAM LLC sold 10,620 Journey Medical shares in Q1 2025, an estimated $41.5K.
  • NWAM LLC first reported a position in Journey Medical in Q1 2024 and held it in 3 quarters.
  • NWAM LLC's Journey Medical position peaked at $58.9K in Q3 2024.
  • 38 funds tracked by Wall St. Rank held Journey Medical as of Q1 2025.

Based on NWAM LLC's 13F filing for Q1 2025, filed 5 May 2025.